What You Should Know:
– Vori Health, the nation’s pioneering physician-led solution for musculoskeletal care, is making waves in the healthcare industry and just announced a $53 million Series B funding round.
– Led by NEA and with continued support from AlleyCorp, Intermountain Health’s Intermountain Ventures, Echo Health Ventures, and Max Ventures, this heavily oversubscribed round is a testament to Vori Health’s rapid growth and innovative care model. In just 18 months, the company has delivered remarkable clinical outcomes and significant cost savings for patients and partners alike, while achieving an 800% revenue increase.
Vori Health Secures Funding to Advance Value-Based Musculoskeletal Care
Vori Health, a physician-led musculoskeletal care provider founded by leading surgeons from Yale and Mayo Clinic, is transforming the U.S. healthcare landscape with its integrated virtual and in-person care model. By combining board-certified physicians, physical therapists, registered dietitians, and health coaches, Vori Health eliminates unnecessary interventions while improving clinical outcomes and reducing costs for employers and health plans.
Since securing Series A funding, the company’s physician-led approach has delivered remarkable results, including:
• 91.6% of patients reporting clinically significant pain improvement
• A 78-90% reduction in elective orthopedic surgeries
• A 42% decrease in opioid utilization
• Up to a 68% reduction in depression and anxiety among patients
The latest funding will accelerate Vori Health’s mission to expand value-based musculoskeletal care nationwide. Key initiatives include:
• Enhancing value-based care models by evolving toward advanced economic frameworks, including two-sided population health risk
• Investing in data analytics to refine risk stratification and improve targeted interventions for high-risk populations
• Advancing AI-powered technology to optimize clinical programs and expand access for patients, employers, and health plan partners
Dr. Ryan Grant, Co-Founder and CEO, emphasized that this investment reinforces the company’s vision of scalable, high-quality musculoskeletal care. The rapid adoption of Vori Health’s platform by Fortune 200 companies and national health plans underscores the demand for its comprehensive solutions.
With this capital infusion, Vori Health aims to redefine musculoskeletal treatment—ensuring it is more effective, accessible, and patient-centered. By optimizing outcomes, reducing unnecessary procedures, and enhancing the overall care experience, the company is leading a fundamental shift toward a more humane and efficient healthcare system.
